Thiophene derivatives as CHK 1 inihibitors

Details for Australian Patent Application No. 2004312193 (hide)

Owner AstraZeneca AB

Inventors Gero, Thomas; Yu, Yan; Toader, Dorin; Lyne, Paul; Ashwell, Susan; Ioannidis, Stephanos; Yu, Dingwei; Janetka, James; Su, Mei

Agent Davies Collison Cave

Pub. Number AU-B-2004312193

PCT Pub. Number WO2005/066163

Priority 60/534,310 05.01.04 US; 60/553,305 15.03.04 US

Filing date 24 December 2004

Wipo publication date 21 July 2005

Acceptance publication date 25 September 2008

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066163 Priority application(s): WO2005/066163

25 September 2008 Application Accepted

  Published as AU-B-2004312193

22 January 2009 Standard Patent Sealed

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312194-Carpet treating composition

2004312186-Method for the synthesis of derivatives of (2S, 3aS, 7aS)-1-[(S)-alanyl]-octahydro-1H-indole -2-carboxylic acid and use thereof for the synthesis of perindopril